Brief: Sab Biotherapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
23/01/2024 23:33
SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE REQUIREMENT
Source text for Eikon: ID:nGNX3281q4
Further company coverage: SABS.O
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies